Lupin has received approval for its Methylprednisolone Tablets USP, 2 mg, 4 mg, 8 mg, 16 mg and 32 mg, from the United States Food and Drug Administration (USFDA) to market a generic version of Pharmacia and Upjohn Company's Medrol tablets, 2 mg, 4 mg, 8 mg, 16 mg and 32 mg.
Methylprednisolone Tablets had annual sales of approximately $114.3 million in the US (IQVIA MAT December 2018).
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.
